Three Drug Ideas that Deserve Redemption
We discuss three life science ideas that struggled on the market, but whose potential impact warrant a second look.
Pfizer: Erecting a New Brand Identity
We examine the aftermath and cost of Pfizer’s major rebranding effort – and discuss where the pharmaceutical giant intends to go from here.